Phase II Clinical Trial of Genexol® (Paclitaxel) and Carboplatin for Patients with Advanced Non-small Cell Lung Cancer

PURPOSE: This phase II clinical trial was conducted to evaluate the activity and safety of a combination treatment of paclitaxel (Genexol®) plus carboplatin in patients with advanced non-small cell lung cancer. MATERIALS AND METHODS: Chemotherapy-naïve patients having histologically confirmed advanc...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Han Jo, Kim, Kyoung Ha, Yun, Jina, Kim, Se Hyung, Kim, Hyun Jung, Lee, Sang-Cheol, Bae, Sang Byung, Kim, Chan Kyu, Lee, Nam Su, Lee, Kyu Taek, Kim, Do-Jin, Park, Seong-Kyu, Won, Jong-Ho, Hong, Dae Sik, Park, Hee Sook
Formato: Texto
Lenguaje:English
Publicado: Korean Cancer Association 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3072531/
https://www.ncbi.nlm.nih.gov/pubmed/21509159
http://dx.doi.org/10.4143/crt.2011.43.1.19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3072531/
https://www.ncbi.nlm.nih.gov/pubmed/21509159
http://dx.doi.org/10.4143/crt.2011.43.1.19

Ejemplares similares